Leading specialist in circular systems
for surgical applications

The Swiss-German company group Vitruvia is a highly specialized company in the European healthcare industry, dedicated to providing innovative and sustainable solutions that deliver advances in medical technology, customer benefits and economic success.

Vitruvia is managed by a well-established team of highly specialized industry experts that has worked together for decades, successfully establishing several disruptive innovations in the market. Its mission at all times is to create the prerequisites that keep modern healthcare affordable—using the latest technologies and processes.

Bertschin-Vitruvia-Web-800x800px

Markus A. Bertschin

PRESIDENT OF THE BOARD OF DIRECTORS


Markus A. Bertschin has many years of financial and management experience through his work for international banks, most recently as Managing Director of Deutsche Bank (Schweiz) AG. Since 2012, he has been concentrating on starting up various companies focusing on innovative production methods.

Torsten-Cejka-Vitruvia-_Web-800x800px

Torsten Cejka

BOARD OF DIRECTORS


As a lawyer specializing in company and medical law, Torsten Cejka is a proven specialist for public limited companies and the necessary capital measures. Mr. Cejka was a managing director in the area of medical device reprocessing and has held further positions on supervisory boards of biotechnology companies.

Dr.-Siever-Vitruvia_Web-800x800px

Dr. Robert Paul Sieber

BOARD OF DIRECTORS


Dr. Sieber is an orthodontics specialist in Switzerland and the USA, who, in 1991, opened what has become the largest orthodontics practice in the Basel region. From 1995 through 2010 he served as President of the Specialization Commission of the Swiss orthodontics association (Schweizerische Gesellschaft für Kieferorthopädie, SGK) and has been an external instructor at the University of Basel since 2016.

Rainer-Grabow-Vitruvia_Web-800x800px

Rainer Grabow

MANAGING DIRECTOR


Rainer Grabow is the co-founder of SterilPlus GmbH, established in 1998, and was responsible for the supply of sterile products to numerous hospitals. In 2002 he changed to the management board of the market leader in reprocessing disposable medical devices. Rainer Grabow has been a managing shareholder of steriPartner GmbH since 2011.

Torsten-Kemnitz

Torsten Kemnitz

MANAGING DIRECTOR


Torsten Kemnitz has been in management roles at well-known companies in the healthcare sector since 2004, including the market leader in reprocessing disposable medical devices and the production of surgical instruments. Torsten Kemnitz is a founding member of steriPartner GmbH.

Claus Wiest Vitruvia

Claus Wiest

MANAGING DIRECTOR


Claus Wiest has been active in the distribution of medical instruments both nationally and internationally since 1998. In 2010, he jointly founded LT technologies GmbH & Co.KG, a successful company for the maintenance and repair of surgical instruments and optics, which he has since led as Managing Director.

Who we are

Vitruvia is Europe‘s foremost technology company in the healthcare sector of the circular economy. As a supplier of innovative circular systems for highly complex medical devices, particularly in robot-assisted surgery, Vitruvia supports hospitals in creating a secure future.

The first European Circular Clinic Supply Center for robotic instruments, established by Vitruvia, sets completely new benchmarks for safe reprocessing of robotic instruments and complex medical devices. In addition to modern validated processes, the use of innovative technologies such as artificial intelligence (AI) ensures the highest standards of processes and hygiene.

Vitruvia is managed by a well-established team of highly specialized industry experts that has worked together for decades, successfully establishing several disruptive innovations in the market. Its mission at all times is to create the prerequisites that keep modern healthcare affordable—using the latest technologies and processes.

The focus of Vitruvia on robotic instruments is aimed at a market with huge growth prospects worldwide. Robot-assisted surgery is revolutionizing healthcare. It is now part of surgical medicine, especially minimally invasive procedures such as complex cancer surgery, and it is here to stay. Compared to the USA and Asia the market in Germany is currently still in its infancy.

History I Milestones on the road to market leadership

Development of processes for reprocessing instruments used in robot-assisted surgery, founding of Vitruvia AG (Switzerland) as financial holding

Founding of Vitruvia GmbH (Germany) as operating company and acquisition of steriPartner GmbH with comprehensive expertise in the reprocessing of surgical instruments

Extension of Vitruvia GmbH in the areas of process development, validation, QM, IT and sales

Acquisition of the property and start of planning and construction activity for the first European Circular Clinic Supply Center for robotic instruments

Grant of funding by the Federal State of Saxony-Anhalt and the European Union and support for hospitals in the fight against the coronavirus pandemic through the supply of personal protective equipment

Acquisition of LT technologies GmbH & Co. KG as a specialist for the cross-manufacturer repair of endoscopic and surgical instruments

Opening of the first European Circular Clinic Supply Center for robotic instruments in Schönebeck/ Elbe and start of the operative business of reprocessing instruments for robot-assisted surgery

Planned listing of Vitruvia Medical AG for trading on the Munich Stock Exchange

Our strategy

Vitruvia balances modern healthcare with economy and sustainability. We want to contribute our part to affordable and efficient modern healthcare by creating effective circular systems for surgical applications. As a “first mover” in the field of robotic instruments, we plan to expand our lead all across Europe.